Citation | Vazquez, ML; Kaila, N; Strohbach, JW; Trzupek, JD; Brown, MF; Flanagan, ME; Mitton-Fry, MJ; Johnson, TA; TenBrink, RE; Arnold, EP; Basak, A; Heasley, SE; Kwon, S; Langille, J; Parikh, MD; Griffin, SH; Casavant, JM; Duclos, BA; Fenwick, AE; Harris, TM; Han, S; Caspers, N; Dowty, ME; Yang, X; Banker, ME; Hegen, M; Symanowicz, PT; Li, L; Wang, L; Lin, TH; Jussif, J; Clark, JD; Telliez, JB; Robinson, RP; Unwalla, R Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J Med Chem61:1130-1152 (2018) [PubMed] Article |
---|
SMILES | CCCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wD:10.12,8.7,(18.14,-11.53,;16.81,-10.76,;15.47,-11.53,;14.14,-10.76,;12.8,-11.53,;13.56,-12.86,;12.03,-12.85,;11.47,-10.77,;10.14,-11.54,;8.65,-11.14,;8.26,-12.64,;9.75,-13.03,;6.93,-13.42,;5.59,-12.65,;6.93,-14.96,;5.61,-15.73,;5.6,-17.27,;6.94,-18.04,;8.28,-17.26,;9.75,-17.73,;10.65,-16.48,;9.73,-15.23,;8.27,-15.72,)| |